Amrize Ltd (NYSE:AMRZ – Get Free Report) CFO Baris Oran acquired 3,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, with a total value of $142,140.00. Following the purchase, the chief financial officer owned 3,000 shares in the company, valued at approximately $142,140. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Amrize Stock Performance
Shares of NYSE AMRZ traded up $0.28 during midday trading on Thursday, reaching $46.65. The company’s stock had a trading volume of 1,261,074 shares, compared to its average volume of 3,206,131. The stock has a market capitalization of $25.80 billion, a P/E ratio of 21.50, a PEG ratio of 1.02 and a beta of 0.11. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The firm has a 50 day moving average price of $51.50 and a 200-day moving average price of $54.58. Amrize Ltd has a 12-month low of $46.03 and a 12-month high of $65.94.
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). The business had revenue of $3.50 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.17%. As a group, equities analysts predict that Amrize Ltd will post 2.72 earnings per share for the current year.
Amrize Announces Dividend
Wall Street Analyst Weigh In
Several brokerages recently weighed in on AMRZ. Weiss Ratings lowered Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, July 31st. Oppenheimer cut their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a research report on Tuesday, July 21st. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the company an “overweight” rating in a research report on Monday, June 22nd. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target on the stock in a research note on Friday, May 1st. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Amrize in a report on Monday, June 22nd. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $60.57.
View Our Latest Research Report on AMRZ
Institutional Investors Weigh In On Amrize
Institutional investors and hedge funds have recently modified their holdings of the company. Geode Capital Management LLC purchased a new position in shares of Amrize during the 2nd quarter valued at $265,000. M&T Bank Corp bought a new position in Amrize in the 2nd quarter worth about $205,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of Amrize during the 2nd quarter valued at about $3,870,000. Gabelli Funds LLC purchased a new position in shares of Amrize during the second quarter worth about $1,083,000. Finally, AXA S.A. purchased a new position in shares of Amrize during the second quarter worth about $1,065,000.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
